SWAN Study: Bone Loss Accelerates Sharply During the Menopause Transition

The Study of Women's Health Across the Nation (SWAN) is the most comprehensive longitudinal study of the menopause transition ever conducted. Published in the Journal of Clinical Endocrinology and Metabolism, SWAN followed 3,302 pre- and early perimenopausal women from five racial and ethnic groups across seven U.S. centers to track bone mineral density changes as they moved through the menopausal transition. The findings revealed a clear pattern: bone density remained relatively stable during premenopause and early perimenopause, then declined sharply during late perimenopause and early postmenopause — averaging approximately 2% per year at the lumbar spine, with greater losses at the spine than at the hip.

Critically, the study showed that this acceleration in bone loss begins before the final menstrual period — during the late perimenopausal phase when menstrual irregularity increases but menstruation has not yet stopped. Body weight emerged as a major modifier of loss rate, while ethnicity per se did not significantly alter the pattern after accounting for body composition.

Why This Matters for Midlife Health

SWAN reframed the timing of bone health risk. The prevailing clinical assumption had been that bone loss was primarily a postmenopausal phenomenon. SWAN showed it begins earlier — during a phase when most women are not yet being screened. This creates a critical window of vulnerability: the years between ages 47 and 55, roughly, when hormonal shifts are driving rapid bone loss but clinical attention has not yet arrived. For women in this window, understanding that bone loss is already underway — even if you are still menstruating — is essential knowledge.

The Tracking Connection

SWAN demonstrated that the menopause transition is not a single event but a multi-year process with distinct phases, each with different implications for bone health. Kairos™ is built around this same understanding. By tracking menstrual patterns, vasomotor symptoms, sleep changes, and other perimenopause indicators alongside bone health data, users can identify where they are in the transition and what that means for their skeleton. When you can see that your symptoms place you in late perimenopause — the phase SWAN identified as the inflection point for bone loss — the case for a baseline DXA scan becomes self-evident.